Boston Scientific announces conference call discussing first quarter 2026 results
Rhea-AI Summary
Boston Scientific (NYSE: BSX) will webcast a conference call to discuss its first quarter ended March 31, 2026 results on April 22, 2026 at 8:00 a.m. ET.
The call will be hosted by Mike Mahoney, chairman and CEO, and Jon Monson, EVP and CFO. A news release with results will be issued before the call; live webcast and replay available at the company's investor site.
Positive
- None.
Negative
- None.
News Market Reaction – BSX
In the Mar 30 session, BSX declined 9.02%, reflecting a notable negative market reaction. Argus tracked a trough of -7.5% from its starting point during tracking. Our momentum scanner triggered 101 alerts that day, indicating very high trading interest and price volatility. Trading volume was above average at 1.6x the daily average, suggesting increased trading activity.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 02 | Earnings & conference plan | Neutral | -0.7% | Outlined JPM conference appearance and Q4/FY 2025 earnings call timing. |
| Sep 02 | Investor day & Q3 call | Neutral | +1.1% | Announced 2025 Investor Day and Q3 2025 earnings conference call schedule. |
| Jul 01 | Q2 2025 call setup | Neutral | -2.5% | Set date and time for Q2 2025 earnings call and webcast access. |
| Apr 01 | Q1 2025 call setup | Neutral | +0.4% | Scheduled Q1 2025 results call with leadership and webcast details. |
| Jan 02 | JPM & Q4 2024 call | Neutral | +0.1% | Announced JPM conference participation and Q4 2024 earnings call timing. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Similar "conferences,earnings" scheduling announcements have historically led to modest share moves, with a slight average negative reaction of -0.32% over the past five tagged events.
Over the past several quarters, Boston Scientific has repeatedly issued combined "conferences,earnings" announcements outlining participation in major healthcare conferences and scheduling quarterly earnings calls. Prior releases on Jan 2, 2025, Apr 1, 2025, Jul 1, 2025, Sep 2, 2025, and Jan 2, 2026 all followed the same template: setting dates and times, naming senior presenters, and confirming that webcasts and replays would be available. Price reactions around these events have been modest, with single‑day moves ranging roughly between about -2.45% and 1.10%, suggesting these notices are treated as routine housekeeping rather than major catalysts.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live webcast and replay for the event will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.
About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.
CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com
Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-first-quarter-2026-results-302727378.html
SOURCE Boston Scientific Corporation